Journal profile · Cell Biology
Cell Cycle
ISSN 1538-4101 · eISSN 1551-4005 · Landes Bioscience · UNITED STATES · Semimonthly · Founded 2002
Cell Cycle: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 4.08; hybrid open access; APC charged, amount not published; median 139 days to acceptance (86 articles, last 24 months); community-reported acceptance: about 50%; 53 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cell Cycle is published by Landes Bioscience and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related Molecular Pathways, Microtubule and mitosis dynamics and DNA Repair Mechanisms, together about 32.9% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Cell Cycle is a peer-reviewed journal of high priority research from all areas of cell biology. Cell Cycle covers all topics from yeast to man, from DNA to function, from development to aging, from stem cells to cell senescence, from metabolism to cell death, from cancer to neurobiology, from molecular biology to therapeutics. Our goal is fast publication of outstanding research. Cell Cycle accepts the following types of article: Research Papers/Reports, Reviews, Perspectives, Letters to the Editor and News and Views. Categories of manuscripts include: Research papers/Reports Perspectives/Reviews Invited follow-ups to important articles published in Cell Cycle and elsewhere: Extra Views, Features, News and Views Please note that this journal only publishes manuscripts in English. Cell Cycle offers online manuscript submission and single anonymized peer-review by independent, anonymous expert referees, as well as a flexible open access policy. The online only journal is indexed by PubMed/Medline, Thomson Reuters, and Scopus. Cell Cycle will, at the discretion of the Chief Editor, consider reviewer reports from previous submission to other high-impact journals for accelerated review. High-priority papers will be peer-reviewed and published as soon as possible. In silico studies and those focused on traditional Chinese medicine will not be considered for publication. Western blots should display complete gels - cropped images of gels are not accepted. Authors can choose to publish gold open access in this journal. Read the Instructions for Authors .
From the journal's Aims & Scope
Research area (LetPub): Cell Biology
Editor-in-chief Gaetano SantulliPublisher website
Editorial board by country: 2 in mainland China (about 5%); most named United States 20, Italy 4, India 3, Mainland China 2, Japan 2 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related Molecular PathwaysMedicine11.6%
- Microtubule and mitosis dynamicsBiochemistry, Genetics and Molecular Biology10.9%
- DNA Repair MechanismsBiochemistry, Genetics and Molecular Biology10.4%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology5.6%
- Genomics and Chromatin DynamicsBiochemistry, Genetics and Molecular Biology5.4%
- Ubiquitin and proteasome pathwaysBiochemistry, Genetics and Molecular Biology5.4%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology5.2%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Cell Biology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCPubMedEmbaseCASCurrent ContentsPublisher website
Other: Thomson Reuters, Adis International Ltd. - Reactions Weekly (Online), EBSCOhost - Biological Abstracts (Online), Thomson Reuters - Biological Abstracts (Online)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.08LetPub ·
- Impact factor (publisher) 2025
- 3.9Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.8Publisher website ·
- CiteScore 2026-06
- 8.7LetPub ·
- CiteScore (publisher) 2025
- 8.7Publisher website ·
- SJR 2026-06
- 0.94LetPub ·
- SJR (publisher) 2025
- 0.94Publisher website ·
- SNIP 2026-06
- 0.77LetPub ·
- SNIP (publisher) 2025
- 0.77Publisher website ·
- h-index
- 128LetPub ·
- h-index
- 203OpenAlex ·
- i10-index
- 7,036OpenAlex ·
- 2-year mean citedness
- 2.47OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 15.35%LetPub ·
Volume
- Articles per year
- 56LetPub ·
- Downloads per year (publisher)
- 1,500,000Publisher website ·
Articles by year OpenAlex count · 9,868 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 58 | 56 | 19 |
| 2025 | 53 | 52 | 72 |
| 2024 | 78 | 78 | 375 |
| 2023 | 136 | 136 | 1,175 |
| 2022 | 299 | 299 | 3,639 |
| 2021 | 234 | 233 | 4,474 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
139 daysMedian, submission to acceptance · P25–P75 93 days – 229 days
- Acceptance to online
- median 15 days (86 articles)
- Submission to online
- median 154 days
- Sample
- 86 articles with submission and acceptance dates (118 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Acceptance rate (publisher)
- 11%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 6 daysPublisher website ·
- Acceptance to publication
- 14 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Not considered
- In silico studies; studies focused on traditional Chinese medicine; cropped images of gels
Article types accepted5
- letters to the editorCell Cycle accepts the following types of article: Research Papers/Reports, Reviews, Perspectives, Letters to the Editor and News and Views.Length not stated
- news and viewsCell Cycle accepts the following types of article: Research Papers/Reports, Reviews, Perspectives, Letters to the Editor and News and Views.Length not stated
- perspectivesCell Cycle accepts the following types of article: Research Papers/Reports, Reviews, Perspectives, Letters to the Editor and News and Views.Length not stated
- research papers/reportsCell Cycle accepts the following types of article: Research Papers/Reports, Reviews, Perspectives, Letters to the Editor and News and Views.Length not stated
- reviewsCell Cycle accepts the following types of article: Research Papers/Reports, Reviews, Perspectives, Letters to the Editor and News and Views.Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Cell Cycle is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership o…
Source ↗Publisher website ·- Peer review
Only publishes manuscripts in English. Model summary
Please note that this journal only publishes manuscripts in English.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Landes Bioscience
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Semimonthly
- Founded
- 2002
- ISSN
- 1538-4101
- Electronic ISSN
- 1551-4005
- Latest issue on the website
- Volume 25, Issue 1 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Cell Cycle
What CAS zone is Cell Cycle in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cell Cycle is in Zone 3 of Biology, and in Zone 4 of the minor category Cell Biology. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cell Cycle?
The latest impact factor listed by LetPub is 4.08; CiteScore 8.7, h-index 203.
How long does peer review take at Cell Cycle?
Based on the dates recorded on 86 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 139 days (interquartile range 93–229 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”; the journal's website gives an acceptance rate of 11%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Cell Cycle based?
Of the 42 board members whose country the journal's board page names, 2 (about 5%) are in mainland China; the countries named most often are United States (20), Italy (4) and India (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Cell Cycle?
According to LetPub and DOAJ records, Cell Cycle is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PMC, PubMed, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Cell Cycle open access, and what is the APC?
Cell Cycle is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .